8-K: Cartesian Growth Corporation II Extends Business Combination Deadline for Seventh Time, Draws Additional Funds
SPAC Business Combination Extension
Cartesian Growth Corporation II has announced its seventh one-month extension to complete an initial business combination, pushing the deadline to July 5, 2025, and drawing an additional $250,000 from a promissory note to fund the extension.
Summary
- Cartesian Growth Corporation II (the "Company") approved its seventh one-month extension for the Business Combination Period.
- The new deadline to consummate an initial business combination is July 5, 2025.
- In connection with this extension, the Company drew $250,000 (the "Extension Funds").
- These funds were drawn from an unsecured promissory note with a principal amount of up to $2,400,000, dated November 6, 2024, in favor of CGC II Sponsor LLC (the "Sponsor").
- The Extension Funds will be deposited into the Company's trust account.
- This is the seventh of twelve one-month extensions permitted under the Company's amended and restated memorandum and articles of association.
Sentiment
Score: 3
Explanation: The seventh extension of the business combination period, coupled with drawing additional funds, indicates ongoing difficulties in securing a merger target, which is typically viewed unfavorably by the market. While it provides more time, it also signals prolonged uncertainty.
Positives
- The Company secured additional time to identify and complete an initial business combination, demonstrating commitment to finding a suitable target.
- The Sponsor continues to provide financial support by funding the extension through the promissory note.
Negatives
- This marks the seventh extension, indicating ongoing challenges or delays in identifying and consummating a suitable business combination.
- Each extension requires drawing additional funds, which, while from a note, represents a cost and potential obligation for the SPAC.
Risks
- Failure to consummate an initial business combination by the extended deadline of July 5, 2025, could lead to the liquidation of the Company.
- The Company's reliance on extensions and additional funding from the Sponsor highlights the difficulty in securing a de-SPAC transaction.
Future Outlook
The Company is actively seeking to consummate an initial business combination, with the current extension providing time until July 5, 2025. The continued use of extensions suggests an ongoing effort to find a suitable target.
Management Comments
- "Cartesian Growth Corporation II approved the seventh one-month extension of the time period during which it may consummate an initial business combination."
- "The Sponsor (or its affiliates or permitted designees) will deposit the Extension Funds into the trust account that was established by the Company in connection with its initial public offering."
Industry Context
This filing is typical for a Special Purpose Acquisition Company (SPAC) that has not yet identified or completed a business combination within its initial timeframe. SPACs often seek extensions to avoid liquidation and provide more time to find a suitable target, especially in a challenging market for de-SPAC transactions. The repeated extensions (seventh of twelve) highlight the increasing difficulty many SPACs face in completing mergers, reflecting broader market sentiment and valuation challenges for private companies seeking to go public via SPACs.
Comparison to Industry Standards
- The need for multiple extensions is common in the current SPAC market, where many SPACs struggle to find attractive targets or complete deals due to market volatility, increased regulatory scrutiny, and investor skepticism.
- While some SPACs successfully complete mergers within their initial term or after one or two extensions, Cartesian Growth Corporation II's seventh extension suggests a more prolonged search, potentially indicating a less favorable market position or more stringent target criteria compared to peers that have either de-SPACed or liquidated earlier.
- The funding mechanism via a sponsor promissory note is a standard practice for SPAC extensions, where the sponsor typically provides capital to extend the life of the SPAC.
Related Party Transactions
- The Company drew $250,000 from an unsecured promissory note in favor of CGC II Sponsor LLC (the Sponsor), which is a related party transaction.
Stakeholder Impact
- Shareholders face continued uncertainty regarding the Company's ability to complete a business combination. The repeated extensions may lead to investor fatigue and potential redemptions if a deal is not announced soon. The value of warrants may also be impacted by prolonged uncertainty.
- The Sponsor (CGC II Sponsor LLC) continues to provide financial support to the Company, indicating ongoing commitment but also increasing its investment risk.
Next Steps
- The Company will continue its efforts to identify and consummate an initial business combination before the new deadline of July 5, 2025.
- The Sponsor will deposit the drawn Extension Funds into the trust account.
Key Dates
| Date | Description |
|---|---|
| 2024-11-06 | Date of the unsecured promissory note in the principal amount of up to $2,400,000. |
| 2025-05-30 | Date of earliest event reported; Company approved the seventh one-month extension of the Business Combination Period. |
| 2025-06-24 | Date the Form 8-K report was signed. |
| 2025-07-05 | New deadline for the Business Combination Period following the seventh extension. |
Recommendation
holdKeywords
Cartesian Growth Corporation II, SPAC, Special Purpose Acquisition Company, Business Combination Extension, Promissory Note, Trust Account, De-SPAC, RENEU, RENE, RENEW, Nasdaq
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.